J. Cradock

发表

Computer-assisted structure-activity correlations of halodideoxynucleoside analogs as potential anti-HIV drugs.

M. Nasr, J. Cradock, M. Johnston, 1992, AIDS research and human retroviruses.

The hydrolysis of spirohydantoin mustard.

J. Kelley, J. Cradock, K. Flora, 1982, Journal of pharmaceutical sciences.

An intravenous formulation of Δ9‐tetrahydrocannabinol using a non‐ionic surfactant

A. Guarino, J. Davignon, C. Litterst, 1973, The Journal of pharmacy and pharmacology.

Diphtheria Toxin‐ and GFP‐Based Mouse Models of Acquired Hypoparathyroidism and Treatment With a Long‐Acting Parathyroid Hormone Analog

Tomoyuki Watanabe, T. Gardella, R. Bi, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Investigational Drug Information

J. Davignon, J. Cradock, L. Trissel, 1979 .

Investigational Drug Information

J. Davignon, J. Cradock, L. Trissel, 1978 .

Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 disease.

W. Pavan, C. Vite, C. Austin, 2014, Current topics in medicinal chemistry.

Disposition and bioavailability of various formulations of tetrahydrocannabinol in the rhesus monkey.

C. Peck, E. Perlin, A. Nichols, 1985, Journal of pharmaceutical sciences.

Therapeutic and pharmacokinetic relationships of flavone acetic acid: an agent with activity against solid tumors.

J. Plowman, D. Zaharko, C. Grieshaber, 1986, Cancer treatment reports.

Enhanced chartreusin solubility by hydroxybenzoate hydrotropy.

J. Cradock, G. Poochikian, 1979, Journal of pharmaceutical sciences.

Overview of the preclinical development of an antiretroviral drug, 2',3'-dideoxyinosine.

H. Mitsuya, S. Broder, J. Tomaszewski, 1990, Reviews of infectious diseases.

Application of a simple high-performance liquid chromatographic method for the determination of melphalan in the presence of its hydrolysis products.

J. Cradock, K. Flora, S. L. Smith, 1979, Journal of chromatography.

In Vivo Efficacy of VT-1129 against Experimental Cryptococcal Meningitis with the Use of a Loading Dose-Maintenance Dose Administration Strategy

A. Wang, E. Garvey, E. Ottinger, 2018, Antimicrobial Agents and Chemotherapy.

The Fungal Cyp51 Inhibitor VT-1129 Is Efficacious in an Experimental Model of Cryptococcal Meningitis

E. Garvey, E. Ottinger, A. Alimardanov, 2018, Antimicrobial Agents and Chemotherapy.

Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions.

J. Cradock, K. Flora, Y. Cheung, 1987, American journal of hospital pharmacy.

Safety, pharmacokinetics and sialic acid production after oral administration of N-acetylmannosamine (ManNAc) to subjects with GNE myopathy.

A. Wang, W. Gahl, M. Huizing, 2017, Molecular genetics and metabolism.

Structure-Activity Correlations of Natural Products with Anti-HIV Activity

M. Nasr, J. Cradock, M. Johnston, 1992 .

Daunomycin metabolism in rat tissue slices.

N. Bachur, J. Cradock, 1970, The Journal of pharmacology and experimental therapeutics.

Hexamethylene bisacetamide: a polar-planar compound entering clinical trials as a differentiating agent.

B. Leyland-Jones, C. Grieshaber, D. Hoth, 1986, Cancer treatment reports.

Simple high-performance liquid chromatographic method for the separation of 3,6-diacetylmorphine hydrochloride (heroin) and hydrolysis products.

J. Cradock, G. Poochikian, 1979, Journal of chromatography.

Stability of anthracycline antitumor agents in four infusion fluids.

J. Cradock, K. Flora, G. Poochikian, 1981, American journal of hospital pharmacy.

Arabinosyl-5-azacytosine: A novel nucleoside entering clinical trials

B. Leyland-Jones, J. Grem, J. Plowman, 1987, Investigational New Drugs.

Determination of Δ9-tetrahydrocannabinol in pharmaceutical vehicles by high-performance liquid chromatography vehicles by high-performance liquid chromatography

J. Davignon, J. Cradock, K. Flora, 1981 .

Cradock of Excipients in injectable Dosage Forms Low Temperature Vacuum Drying : Evaluation on September

A. Rahman, J. Cradock, K. Flora, 2011 .

Determination of ellipticine in biological samples by high-performance liquid chromatography.

J. Cradock, K. Flora, G. Poochikian, 1982, Journal of chromatography.

Compatibility of plastic infusion devices with diluted N-methylformamide and N,N-dimethylacetamide.

J. Cradock, B. Vishnuvajjala, 1984, American journal of hospital pharmacy.

Trimetrexate: a new antifol entering clinical trials

B. Leyland-Jones, P. O'dwyer, J. Plowman, 2004, Investigational New Drugs.

Reduction of pyrogens—application of molecular filtration ‡

S. L. Morgan, J. Cradock, D. L. Francis, 1978, The Journal of pharmacy and pharmacology.

Flavone acetic acid (LM 975, NSC 347512) A novel antitumor agent

B. Leyland-Jones, P. O'dwyer, F. Valeriote, 1987, Cancer Chemotherapy and Pharmacology.

Heroin: Stability and formulation approaches

J. Davignon, J. Cradock, G. Poochikian, 1983 .

2,5-Diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone I: Kinetics in aqueous solutions by high-performance liquid chromatography.

J. Cradock, G. Poochikian, 1981, Journal of pharmaceutical sciences.

Evaluation of some pharmaceutical aspects of intrathecal methotrexate sodium, cytarabine and hydrocortisone sodium succinate.

A. Rahman, J. Cradock, L. M. Kleinman, 1978, American journal of hospital pharmacy.

Formulation of three nitrosoureas for intravenous use.

J. Davignon, J. Cradock, H. Wood, 1973, Cancer chemotherapy reports. Part 3.

Uridine‐induced hyperthermia in the rabbit

H. D. Hochstein, H D Hochstein, T F Chin, 1986, The Journal of pharmacy and pharmacology.

Dissolution and absorption of the antineoplastic agent ellipticine.

J. Davignon, A. Rahman, J. Cradock, 1978, Journal of pharmaceutical sciences.